comparemela.com

Latest Breaking News On - Paul matteis - Page 7 : comparemela.com

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2023 Earnings Call Transcript

Operator: Hello, thank you for standing by. And welcome to Xenon Pharmaceuticals Incorporated Third Quarter 2023 Earnings Conference Call.

Dublin
Ireland
United-states
American
Ian-mortimer
Sanjay-mathew
James-murrow
Paul-matteis
Sherry-aulin
Brian-abrahams
Chris-kenney
American-epilepsy-society-meeting

Biogen (BIIB) Q3 2023 Earnings Call Transcript

BIIB earnings call for the period ending September 30, 2023.

China
Argentina
United-states
Japan
Brazil
Turkey
Terence-flynn-morgan-stanley
Mike-mcdonnell
Robyn-karnauskas-truist
Salveen-richter-goldman-sachs
Brian-abrahams
Chuck-triano

Biogen, Sage set price of postpartum depression pill at $15,900

BioPharma

Barry-greene
Paul-matteis
Drug-enforcement-administration
Drug-administration
Dive-brief
Sage-therapeutics
Drug-enforcement
Marketing
Drug-pricing

These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q3 Results - Vertex Pharmaceuticals (NASDAQ:VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported upbeat earnings for its third quarter, while sales missed estimates.

Paul-matteis
Evan-seigerman
Andrew-fein
Olivia-brayer
Brian-abrahams
Hc-wainwright-co
Cantor-fitzgerald
Vertex-pharmaceuticals-incorporated
Vertex-pharmaceuticals
Costco
Sector-perform
Read-this

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q3 2023 Earnings Conference Call. At this time, participants are in a listen-only mode.

Germany
United-states
Canada
Netherlands
Japan
Italy
Spain
United-kingdom
Pushkal-garg
Yvonne-greenstreet
Paul-matteis
Tolga-tanguler

vimarsana © 2020. All Rights Reserved.